Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Betula Pubescens Flower Bud And Juniperus Communis Stem
Brand Name
G-48
Generic Name
Betula Pubescens Flower Bud And Juniperus Communis Stem
Active Ingredient
Betula Pubescens Flower BudCategory
Non-Standardized Pollen Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 [hp_X]/mL | SOLUTION | SUBLINGUAL | 58264-0411 |
Detailed information about G-48
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for G-48, you must consult a qualified healthcare professional.
Betula Pubescens Flower Bud is a non-standardized pollen allergenic extract utilized in the diagnosis and treatment of Type I hypersensitivity reactions. It belongs to the class of allergenic extracts used to induce immune tolerance in patients with birch-pollen-induced allergic rhinitis.
The dosing of Betula Pubescens Flower Bud extract is divided into two distinct phases: the Build-up Phase and the Maintenance Phase.
During this initial period, the dose is started at a very low concentration (often 1:100,000 or 1:10,000 w/v) and is increased incrementally once or twice weekly. The goal is to reach the 'maintenance dose,' which is the highest dose that the patient can tolerate without significant local or systemic side effects. This phase typically lasts 3 to 6 months.
Once the maintenance dose is reached, the frequency of administration is decreased. For subcutaneous injections, this usually involves one injection every 2 to 4 weeks. This phase is generally continued for 3 to 5 years to ensure long-term immunological memory and symptom relief.
Betula Pubescens Flower Bud extracts are generally approved for use in children aged 5 years and older. The dosing schedule for pediatric patients is often similar to that of adults, though healthcare providers may exercise greater caution during the build-up phase. Clinical studies have shown that early intervention with allergen immunotherapy in children may prevent the 'allergic march,' potentially reducing the risk of developing asthma later in life. Use in children under 5 years of age is generally not recommended due to the difficulty of communicating symptoms of an impending systemic reaction.
No specific dosage adjustments are required for patients with renal impairment, as the proteins are primarily degraded proteolytically. However, the patient's overall health and ability to tolerate a systemic reaction should be considered.
No dosage adjustments are necessary for hepatic impairment.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk-benefit ratio must be carefully weighed, as older adults may be less able to tolerate the hemodynamic stress of a severe systemic allergic reaction (anaphylaxis) or the epinephrine used to treat it.
Store the extract in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has passed. If a maintenance dose is missed by more than a week, contact your allergist. Do not double the dose to catch up, as this significantly increases the risk of a severe allergic reaction.
An overdose of Betula Pubescens Flower Bud extract (receiving a dose higher than the tolerated level) primarily manifests as a severe systemic allergic reaction. Signs include generalized hives, swelling of the throat, wheezing, low blood pressure, and loss of consciousness. Emergency treatment involves the immediate administration of epinephrine and supportive care. Seek emergency medical attention if you suspect an overdose or experience symptoms of anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or the timing of your injections without medical guidance, as even small changes can lead to serious safety risks.
The most frequent side effects associated with Betula Pubescens Flower Bud extract are local reactions at the site of administration. For subcutaneous injections, this includes redness (erythema), itching (pruritus), and swelling (edema) at the injection site. These reactions typically appear within minutes and resolve within a few hours. In sublingual therapy, common effects include itching of the mouth (oral pruritus), throat irritation, and mild swelling of the tongue or lips. These 'local' symptoms are generally considered a sign that the immune system is interacting with the allergen.
Some patients may experience 'large local reactions,' where the swelling at the injection site exceeds 5-10 cm in diameter. Other less common effects include:
Rarely, patients may experience systemic reactions that are not life-threatening but require medical attention. These include:
> Warning: Stop taking Betula Pubescens Flower Bud and call your doctor immediately or seek emergency care if you experience any of the following:
There are no known long-term 'toxic' effects of Betula Pubescens Flower Bud extract, as it is a natural protein-based substance. The primary long-term effect is the desired modulation of the immune system. However, patients should be monitored for the development of Eosinophilic Esophagitis (EoE) if using sublingual forms, characterized by persistent difficulty swallowing or chest pain.
Allergenic extracts, including Betula Pubescens Flower Bud, carry a significant warning regarding the risk of severe systemic reactions.
Report any unusual symptoms, even if they seem mild, to your healthcare provider. Early identification of increasing sensitivity is crucial for adjusting the dose and maintaining safety.
Betula Pubescens Flower Bud extract is a potent biological agent. Its use requires a high level of patient compliance and medical supervision. Patients must understand that while the goal is to reduce allergy symptoms, the treatment itself involves exposure to the very substance that causes their allergies. Therefore, the risk of an allergic reaction is always present during the course of therapy.
No FDA black box warnings for Betula Pubescens Flower Bud specifically exist in the same format as small-molecule drugs, but the class-wide 'Boxed Warning' for allergenic extracts is strictly applied. This warning emphasizes that the extract can cause severe anaphylaxis, which may be fatal. It mandates that the product be used only in settings equipped with emergency resuscitative equipment and by personnel trained in treating anaphylaxis. It also notes that patients taking beta-blockers may be resistant to the effects of epinephrine, making a reaction more difficult to treat.
Betula Pubescens Flower Bud extract does not typically cause sedation. However, if a patient experiences a systemic reaction or feels faint/dizzy after an injection, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.
There is no direct chemical interaction between alcohol and the extract. However, alcohol consumption can increase blood flow to the skin and may potentially accelerate the absorption of the allergen or worsen the symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours after an injection.
If treatment is stopped for an extended period, the patient loses their 'tolerance.' Tapering is not required to stop, but restarting therapy usually requires 're-priming' the immune system with a new build-up phase starting from a very low dose.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Betula Pubescens Flower Bud.
While there are few 'absolute' drug contraindications, the following must be managed with extreme caution:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or heart rhythm.
Betula Pubescens Flower Bud extract must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by an expert allergist:
Patients who are allergic to Betula Pubescens may also show cross-sensitivity to other members of the Betulaceae family, such as Alder (Alnus), Hazel (Corylus), and Hornbeam (Carpinus). If a patient has had a severe reaction to any of these tree pollens, the initial dose of Betula Pubescens should be even more conservative.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and current medications, before prescribing Betula Pubescens Flower Bud.
Betula Pubescens Flower Bud extract is generally classified similarly to FDA Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to maternal hypotension, which causes uterine hypoperfusion and fetal hypoxia (lack of oxygen to the baby).
It is not known whether the allergenic components of Betula Pubescens Flower Bud are excreted in human milk. However, since these are proteins that would likely be digested in the infant's gastrointestinal tract, the risk to a nursing infant is considered negligible. The decision to continue immunotherapy while breastfeeding should be based on the mother's clinical need for the treatment.
As previously mentioned, the safety and efficacy of Betula Pubescens extracts have been established in children 5 years of age and older. Pediatric patients often respond very well to immunotherapy. However, the clinician must ensure the child is capable of reporting early symptoms of a reaction. The use of sublingual therapy (SLIT) is often preferred in children to avoid the 'needle phobia' associated with weekly injections.
In patients over 65, the risk-benefit profile changes. Older adults are more likely to have co-morbidities like coronary artery disease or hypertension. They are also more likely to be taking medications like beta-blockers or ACE inhibitors. The physician must ensure that the patient's cardiovascular system can handle the potential 'adrenaline rush' required to treat a reaction. If the allergy symptoms are not severely impacting the patient's quality of life, immunotherapy may be avoided in favor of safer symptomatic treatments.
There is no evidence that renal impairment alters the response to allergenic extracts. However, since the management of a severe reaction may involve fluid resuscitation and various medications, the patient's overall renal health should be considered in the context of emergency preparedness.
No specific studies have been conducted, but hepatic impairment is not expected to significantly impact the safety or efficacy of this protein-based biological product.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment and frequent monitoring during the course of immunotherapy.
Betula Pubescens Flower Bud extract works through a process of 'desensitization' or 'hypo-sensitization.' The major allergen involved is Bet v 1, a 17-kDa protein that belongs to the Pathogenesis-Related protein family (PR-10).
Upon repeated administration, the extract induces the following changes:
The pharmacodynamic effect is measured by a decrease in the 'Late-Phase Response' (LPR) to allergen challenge. While the 'Early-Phase Response' (the immediate sneeze) is reduced, the most significant clinical benefit comes from the reduction in LPR, which involves the recruitment of eosinophils and chronic tissue inflammation. The onset of action is slow, often taking 3 to 6 months to see initial improvement, with peak effects occurring after 1 to 2 years of continuous treatment.
| Parameter | Value |
|---|---|
| Bioavailability | High (local immune interaction); Low (systemic protein) |
| Protein Binding | N/A (Interacts with IgE/IgG antibodies) |
| Half-life | Days (Proteins); Years (Immunological memory) |
| Tmax | 1-2 hours (Local absorption) |
| Metabolism | Proteolytic degradation |
| Excretion | Renal (as amino acids/peptides) |
Betula Pubescens Flower Bud extract is a sterile liquid containing a mixture of water-soluble proteins, glycoproteins, and polysaccharides. The molecular weight of the primary allergens ranges from 10 kDa to 70 kDa. It is typically standardized or measured in PNU (Protein Nitrogen Units) or w/v (Weight/Volume) ratios. The solution is usually buffered with sodium chloride and may contain phenol as a preservative to maintain sterility.
It is classified as a Non-Standardized Pollen Allergenic Extract. It shares therapeutic goals with other allergenic extracts like those for Timothy Grass, Ragweed, and Dust Mites. Within the broader pharmacological landscape, it is considered a 'Biologic Response Modifier.'
Common questions about G-48
Betula Pubescens Flower Bud extract is primarily used for allergen immunotherapy, commonly known as allergy shots or drops. It is designed to treat patients who have a confirmed allergy to birch tree pollen, which often causes symptoms like sneezing, itchy eyes, and nasal congestion. By exposing the body to small, increasing amounts of the birch allergen, the treatment helps the immune system become less sensitive over time. This can lead to a significant reduction in allergy symptoms and a decreased need for daily medications. It is also used by doctors as a diagnostic tool during skin prick testing to identify specific allergies.
The most common side effects are local reactions at the site where the medication was administered. For those receiving injections, this typically involves redness, itching, and a small bump or swelling on the arm, similar to a mosquito bite. Patients using sublingual (under-the-tongue) drops often experience itching or tingling in the mouth and a mild sore throat. These reactions are usually mild and go away within a few hours. However, it is important to monitor these local reactions, as a sudden increase in their size can sometimes predict a more significant reaction later in the treatment.
There is no known direct chemical interaction between alcohol and birch pollen extract. However, most allergists recommend avoiding alcohol for several hours before and after receiving an allergy injection. Alcohol can dilate blood vessels and increase blood flow, which might theoretically speed up the absorption of the allergen into the bloodstream, increasing the risk of a systemic reaction. Additionally, alcohol can sometimes worsen the symptoms of an existing allergic reaction, such as hives or flushing. It is best to remain sober and alert so you can accurately monitor yourself for any delayed side effects following your treatment.
Allergy immunotherapy with Betula Pubescens is generally not started during pregnancy. This is because the 'build-up' phase carries a higher risk of causing a severe allergic reaction, which could reduce oxygen flow to the developing baby. However, if a woman is already on a stable maintenance dose and is tolerating the treatment well, most healthcare providers allow her to continue the therapy throughout pregnancy. The primary goal is to avoid any new risks while maintaining the mother's respiratory health. Always inform your allergist immediately if you become pregnant or are planning to conceive.
Allergen immunotherapy is not an immediate fix for allergies; it is a long-term treatment. Most patients begin to notice an improvement in their symptoms within 3 to 6 months, usually after they have reached the maintenance dose. However, the full benefits are typically not realized until the patient has been on the treatment for at least one full birch pollen season. For the most lasting results, doctors usually recommend continuing the treatment for 3 to 5 years. This duration helps ensure that the immune system's 'tolerance' remains even after the treatment is stopped.
Yes, you can stop taking the extract suddenly without experiencing a 'withdrawal' like you might with some other medications. However, stopping the treatment prematurely will likely result in the return of your allergy symptoms over time. If you stop during the build-up phase, you will lose any progress you have made toward desensitization. If you need to pause treatment due to illness or travel, your doctor will provide a plan for safely restarting, which may involve a lower dose to ensure your safety. Always discuss your plans with your allergist before interrupting your schedule.
If you miss a dose, you should contact your allergist's office for instructions. The protocol for a missed dose depends on how long it has been since your last administration and whether you are in the build-up or maintenance phase. If only a few days have passed, you may be able to continue with your scheduled dose. If several weeks have passed, your doctor may need to reduce your dose temporarily to prevent a reaction. Never try to 'make up' for a missed dose by taking more than prescribed, as this significantly increases the risk of anaphylaxis.
There is no clinical evidence to suggest that Betula Pubescens Flower Bud extract causes weight gain. The extract consists of proteins and glycoproteins that are administered in very small quantities, and it does not affect the metabolic or hormonal systems that typically regulate weight. If you experience weight changes while on this treatment, it is likely due to other factors, such as lifestyle changes or other medications you may be taking (like oral corticosteroids for asthma). If you have concerns about your weight, discuss them with your primary care physician.
Betula Pubescens can be taken alongside most common medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Most patients continue to take their usual allergy medications, like antihistamines or nasal sprays, during the early stages of immunotherapy. Over time, as the immunotherapy becomes effective, many patients find they can reduce or eliminate their use of these other drugs. Always provide your allergist with a complete list of your current medications.
Allergenic extracts like Betula Pubescens are biological products rather than simple chemical drugs, so the term 'generic' does not apply in the traditional sense. Different manufacturers may produce their own versions of Downy Birch extract, but these are not considered interchangeable. Each manufacturer's extract may have different concentrations and protein profiles. Therefore, if you start treatment with one brand of extract, your doctor will typically keep you on that same brand for the duration of your therapy to ensure consistent dosing and safety.
Other drugs with the same active ingredient (Betula Pubescens Flower Bud)